SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Brickwork Ratings upgrades ratings of Nectar Lifesciences’ bank facilities

28 Mar 2014 Evaluate

Credit rating agency, Brickwork Ratings has upgraded rating of Nectar Lifesciences’ long term bank facilities to ‘A’ from ‘A-’. The rating implies adequate degree of safety regarding timely servicing of financial obligation and such investment carry low credit risk.

The rating agency has also upgraded rating of the company’s short term bank facilities to ‘A2+’ from ‘A1’. The rating implies strong degree of safety regarding timely payment of financial obligation and such investment carry low credit risk.

Nectar Lifesciences is a $200 million pharmaceutical organization. The company offers a range of Cephalosporin active pharmaceutical ingredients (APIs) and finished dosage forms.

 

Nectar Lifesciences Share Price

12.66 0.25 (2.01%)
17-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1675.20
Dr. Reddys Lab 1235.40
Cipla 1238.30
Zydus Lifesciences 942.55
Lupin 2324.25
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×